IndraLab
Statements
reach
"LN5P45 treatment reduced RIPK3 protein levels by increasing the K48 ubiquitination of RIPK3, further confirming that OTUB2 deubiquitinates RIPK3 through the enzymatic activity.Pharmacological inhibition of OTUB2 by LN5P45 significantly reduced ischemic stroke injury in mice, indicating that specific and potent OTUB2 inhibitors are competitive candidates for drugs treating ischemic stroke."